Companies are relying more on psychological testing to evaluate general counsel candidates, using everything from quick online assessments to multihour sessions with industrial psychologists. While ...
Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients with newly diagnosed prostate cancer considering first-line treatment, ...
Tests do not consistently influence risk classification or treatment decisions; authors call for well-designed trials on role of GC tests in newly diagnosed PCa. (HealthDay News) — For patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results